Last C$1.50 CAD
Change Today -0.07 / -4.46%
Volume 401.0
As of 1:26 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Peter A. Thompson M.D., FACP

Executive Chairman, Chairman of Corporate Governance & Nominating Committee and Chairman of Option Committee, Response Biomedical Corp.
AgeTotal Calculated CompensationThis person is connected to 61 board members in 5 different organizations across 8 different industries.

See Board Relationships
53C$80,100

Background*

Dr. Peter A. Thompson, M.D., FACP, is a Founder of Cleave Biosciences Inc. Dr. Thompson founded Strategicon Partners and serves as its Managing Director. Dr. Thompson serves as a Venture Partner with OrbiMed Advisors, LLC. He is a Co-founded of Emergent Product Development Seattle, LLC and served as its President and Chief Executive Officer from May 2002 to November 16, 2009. He served as Interim Chief Executive Officer of Response Biomedical Corp., from August 9, 2011 ...

Read Full Background

Corporate Headquarters*

1781 - 75th Avenue West
Vancouver, British Columbia V6P 6P2

Canada

Phone: 604-456-6010
Fax: 604-456-6066

Board Members Memberships*

Co-Founder
DirectorFormer Director
Director
Founder and Director
2002-2009
Co-Founder
2010-Present
Executive Chairman, Chairman of Corporate Governance & Nominating Committee and Chairman of Option Committee
2011-Present
Director, Member of Compensation Committee and Member of Audit Committee
2011-2013
Former Director, Member of Audit Committee and Member of Compensation Committee
2012-Present
Director

Education*

BS
Brown University
MD
Brown University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash CompensationC$26,500
Total Calculated CompensationC$80,100
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RBM:CN C$1.50 CAD -0.07

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John L. Bishop Chairman, Chief Executive Officer and Member of Equity Incentive Committee
Cepheid
$577.2K
Vincent A. Forlenza BDChairman, Chief Executive Officer and President
Becton, Dickinson and Company
$930.0K
Douglas C. Bryant Chief Executive Officer, President and Director
Quidel Corp.
$509.1K
Josef Kaeser Chief Executive Officer, President, Member of The Managing Board and Member of Equity & Employee Stock Committee
Siemens Aktiengesellschaft
€2.2M
Compensation as of Fiscal Year 2013.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RESPONSE BIOMEDICAL CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.